GEN recently published a list of the top 10 worst stock performers of 2013—the 10 biotech, pharma, tools/tech, and services (CROs) company stocks whose prices fell the most during the past year. Which of the firms on this list do you think could turn things around in the near future?
Poll Question:
Which of our 10 Wall Street Losers do you think is most likely to recuperate and go back up in value?
Amarin
12
Amicus Therapeutics
9
Ariad Pharmaceuticals
56
Aveo Oncology
19
BG Medicine
10
GTx
7
Pernix Therapeutic Holdings
4
Prima BioMed
10
Vical
8
XTL Biopharmaceuticals
4
